Advisory Services Network’s Ironwood Pharmaceuticals IRWD Stock Holding History

Advisory Services Network’s Portfolio IRWD Stock Details IRWD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-235	Closed	-$825	–	3431
2026 Q1	$825	Buy	+235	New	+$963	﹤0.01%	4350
2024 Q1	–	Sell	-2,118	Closed	-$24.2K	–	2560
2023 Q4	$24.2K	Buy	+2,118	New	+$20.9K	﹤0.01%	2417
2023 Q2	–	Sell	-2,633	Closed	-$27.7K	–	2534
2023 Q1	$27.7K	Sell	2,633 -380	-13%	-$4.26K	﹤0.01%	2359
2022 Q4	$37.3K	Buy	+3,013	New	+$34.2K	﹤0.01%	2135
2021 Q3	–	Sell	-100	Closed	-$1K	–	2331
2021 Q2	$1K	Buy	+100	New	+$1.15K	﹤0.01%	3474
2021 Q1	–	Sell	-100	Closed	-$1K	–	2144
2020 Q4	$1K	Sell	100 -5	-5%	-$55	﹤0.01%	3155
2020 Q3	$1K	Buy	+105	New	+$1.04K	﹤0.01%	3335
2020 Q2	–	Sell	-100	Closed	-$1K	–	1894
2020 Q1	$1K	Buy	+100	New	+$1.18K	﹤0.01%	2893

Other funds holding IRWD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $178M AUM 118.43% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Advisory Services Network's IRWD Position: Q2 2026 in Review

Advisory Services Network sold out of Ironwood Pharmaceuticals (IRWD) in Q2 2026, closing a stake of 235 shares — an estimated $825 sold.

Advisory Services Network first reported a position in IRWD in Q1 2020 and held it in 8 quarters. The position peaked at $37.3K in Q4 2022. 212 funds tracked by Wall St. Rank hold IRWD as of Q2 2026.

Advisory Services Network reported no remaining Ironwood Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Advisory Services Network sold 235 Ironwood Pharmaceuticals shares in Q2 2026, an estimated $825.
Advisory Services Network first reported a position in Ironwood Pharmaceuticals in Q1 2020 and held it in 8 quarters.
Advisory Services Network's Ironwood Pharmaceuticals position peaked at $37.3K in Q4 2022.
212 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q2 2026.

Based on Advisory Services Network's 13F filing for Q2 2026, filed 12 Aug 2026.